Treating Blood Cancers

Frank Penedo, Ph. D, University of Miami, Miami, FL Recorded on August 10, 2023 Frank Penedo, Ph. D Professor, Departments of Psychology and Medicine Associate Director for Cancer Survivorship and Translational Behavioral Sciences University of Miami Sylvester Comprehensive Cancer Center Sylvester DCC Endowed Chair in Cancer Survivorship University of Miami Miami, FL Tune in as we’re joined by Dr....

John Salsman, Ph. D, Wake Forest University School of Medicine, Winston-Salem, NC Recorded on June 22, 2023 John Salsman, Ph. D Director, Clinical Research in Adolescent and Young Adult (AYA) Oncology Co-Leader, Cancer Prevention and Control Program at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center Professor, Department of Social Sciences and Health Policy at the Wake Forest Uni...

Tung Wynn, MD, University of Florida, Gainesville, FL and Braulio Hernandez Recorded on June 10, 2023 Join Dr. Tung Wynn from the University of Florida, and Braulio Hernandez, a childhood cancer advocate and AYA survivor of Hodgkin Lymphoma, as they discuss the unique experiences of adolescents and young adults from active treatment to survivorship. Dr. Wynn and Braulio reflect on the physical and...

Chasity Burrows Walters, PhD, RN, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on April 13, 2023 Chasity Burrows Walters, PhD, RN Vice President, Educational, Clinical, & Patient Communication Memorial Sloan Kettering Cancer Center New York, NY In this important conversation, Dr. Chasity Burrows Walters from Memorial Sloan Kettering Cancer Center discusses the barriers that pe...

Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI Recorded on January 24, 2023 Ehab Atallah, MD Professor of Medicine Associate Director, Cancer Service Line Section Head, Hematologic Malignancies Division of Hematology and Oncology Medical College of Wisconsin Milwaukee, WI In this episode, Dr. Ken Miller sits down with Dr. Ehab Atallah, from the Medical College of Wisconsin, to discu...

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2022 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide an update on the information presented at th...

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA Recorded on December 6, 2022 Shayna Sarosiek, MD Assistant Professor Harvard Medical School Dana Farber Cancer Institute Boston, MA Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer dis...

Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX Recorded on December 16, 2022 Sattva S. Neelapu, MD Professor and Deputy Chair Department of Lymphoma and Myeloma The University of Texas M.D. Anderson Cancer Center Houston, TX Chimeric antigen receptor (CAR) T-cell therapy has generated impressive results in hematologic malignancies, with many drugs still in clinical trials. In this...

Daphne Friedman, MD, Durham VA Health Care System, Durham, NC Recorded on October 20, 2022 Daphne Friedman, MD Staff Oncologist, Durham VA Health Care System Associate Professor, Duke University School of Medicine Durham, NC In Part II of Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia, Dr. Daphne Friedman, from the Durham VA Health Care System in North Carolina, discus...

Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 7, 2022 Eytan M. Stein, MD Chief, Leukemia Service Director, Program for Drug Development in Leukemia Associate Attending Physician Leukemia Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York, NY Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joins us to reflect...

Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on September 30, 2022 Saad Z. Usmani, MD, MBA, FACP Hematologic Oncologist Chief, Myeloma Service Memorial Sloan Kettering Cancer Center New York, NY Join us for this special episode, recorded live from the Tenth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conferenc...

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX Recorded on September 6, 2022 Naveen Pemmaraju, MD Associate Professor Department of Leukemia Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, TX Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (B...

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA Recorded on July 19, 2022 Jason Gotlib, MD Professor of Medicine in the Division of Hematology Stanford Cancer Institute Stanford University School of Medicine Palo Alto, CA Mastocytosis is a rare and complex disease. In this special episode, Dr. Jason Gotlib from the Stanford University School of Medicine in Palo Alto, CA, di...

Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ Recorded on June 30, 2022 Rafael Fonseca, MD, Chief Innovation Officer Getz Family Professor of Cancer Mayo Clinic Phoenix, AZ In this episode, Dr. Rafael Fonseca, from the Mayo Clinic in Arizona, joins Dr. Ken Miller to breakdown the complex and complicated nature of genomics and molecular profiling. He discusses the role of molecular profiling in trea...

Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC Recorded on June 9, 2022 Kevin C. Oeffinger, MD, FASCO Director, Duke Cancer Institute (DCI) Center for Onco-Primary Care Director, DCI Supportive Care and Survivorship Center Professor of Medicine, Division of Medical Oncology Department of Medicine Duke University Medical Center Durham, NC Children diagnosed with cancer ar...

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on May 20, 2022 Gwen L. Nichols, MD Chief Medical Officer The Leukemia & Lymphoma Society Rye Brook, NY Through the LLS Children’s Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families,...

Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ Recorded on May 3, 2022 Zalman Suldan, MD, PhD Attending Physician Hackensack University Medical Center Hackensack Meridian Health Hackensack, NJ The primary care physician plays an important role in the treatment of patients living with a chronic blood disorder, from early diagnosis to...

Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX Recorded on April 8, 2022 Rayne H. Rouce, MD, BS Associate Professor Department of Pediatrics Texas Children’s Cancer Center for Cell and Gene Therapy Baylor College of Medicine Houston, TX As CAR T-cell therapy continues to evolve in new and exciting ways, new indications are approved and treatment toxic...

Francine Foss, MD and John A. Zic, MD, MMHC Recorded on March 28, 2022 This informative episode covers everything you need to know about cutaneous T-cell lymphoma, from its biology, subclassifications, targeted therapy, goals of treatment, novel toxicities, and so much more! Join Dr. Ken Miller as he delves into cutaneous T-cell lymphoma with two special guests; Dr. Francine Foss from Yale Univers...

Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX Recorded on February 18, 2022 Srdan Verstovsek, MD, PhD Professor of Medicine Director, Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms Department of Leukemia MD Anderson Cancer Center Houston, TX In this month’s episode, Dr. Srdan Verstovsek, from MD Anderson Cancer Center in Houston, Texas, joins us to d...

Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY Recorded on February 1, 2022 Jacqueline C. Barrientos, MD, MS Professor of Medicine Zucker School of Medicine at Hofstra/Northwell CLL Research & Treatment Program Hempstead, NY Shared decision making between patients and their healthcare team is an important component to treatment, regardless of th...

Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on January 4, 2022 Caron Jacobson, MD Assistant Professor of Medicine Harvard Medical School Medical Director Immune Effector Cell Therapy Program Dana-Farber Cancer Institute Boston, MA As we move into 2022, chimeric antigen receptor (CAR) T-cell therapy continues to be a very exciting and effective treatment option for some bl...

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 22, 2021 Each year, blood cancer professionals gather at the American Society of Hematology Annual Meeting to discuss the latest updates in blood cancer research, treatment, and clinical trials. In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia &...

John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY Recorded on December 16, 2021 As 2021 comes to a close, the COVID-19 pandemic continues to evolve. In this episode, Dr. John Leonard, from Weill Cornell Medicine, New York Presbyterian Hospital, discusses the latest updates on how COVID-19 affects the blood cancer patient population. What is the value of the vaccine i...

Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX Recorded on October 21, 2021 In this episode, Dr. Maria Alma Rodriguez from The University of Texas MD Anderson Cancer Center, joins us in discussing the long-term and late effects of cancer treatment, including strategies to support survivors with physical and psychosocial effects. Dr. Rodriguez de...